Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Ruiz Camps

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Therapeutic Advances in Infectious Disease|March 8, 2021
Risk of infection associated with targeted therapies for solid organ and hematological malignanciesIsabel Ruiz-Camps, Juan Aguilar-Company
Infectious Disease Clinics of North America|April 27, 2020
Epidermal Growth Factor Receptor Inhibitors and Other Tyrosine Kinase Inhibitors for Solid TumorsIsabel Ruiz-Camps, Juan Aguilar-Company
Enfermedades Infecciosas Y Microbiologia Clinica|June 22, 2014
[Nosocomial infection in patients receiving a solid organ transplant or haematopoietic stem cell transplant]Asunción Moreno Camacho, Isabel Ruiz Camps
Enfermedades Infecciosas Y Microbiologia Clinica|October 20, 2012
[Invasive fungal infection in haematology patients]J Carlos Vallejo Llamas, Isabel Ruiz-Camps
Enfermedades Infecciosas Y Microbiologia Clinica|July 22, 2006
[Special features of febrile neutropenia in pediatric patients]M Teresa Olivé-Oliveras, Isabel Ruiz-Camps
Medicina Clinica|November 28, 2019
Risk of infection associated with new therapies for lymphoproliferative syndromesIbai Los-Arcos, Juan Aguilar-Company, Isabel Ruiz-Camps
Revista Iberoamericana De Micologia|July 23, 2021
[Invasive fungal infection over the last 30 years]José Tiago Silva, Isabel Ruiz-Camps, José María Aguado
Frontiers in Medicine|August 1, 2022
Multidisciplinary approach to treatment with immune checkpoint inhibitors in patients with HIV, tuberculosis, or underlying autoimmune diseasesJuan Aguilar-Company, Maria A Lopez-Olivo, Isabel Ruiz-Camps
Journal of Clinical Microbiology|October 4, 2019
Molecular Diagnosis of <i>Pneumocystis jirovecii</i> Pneumonia by Use of Oral Wash Samples in Immunocompromised Patients: Usefulness and Importance of the DNA TargetLidia Goterris, Miguel Angel Mancebo Fernández, Juan Aguilar-Company, et al.
Antimicrobial Agents and Chemotherapy|December 14, 2016
Salvage Therapy with Ceftolozane-Tazobactam for Multidrug-Resistant Pseudomonas aeruginosa InfectionsJuan José Castón, Álvaro De la Torre, Isabel Ruiz-Camps, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Therapeutic Advances in Infectious Disease|March 8, 2021
Risk of infection associated with targeted therapies for solid organ and hematological malignanciesIsabel Ruiz-Camps, Juan Aguilar-Company
Infectious Disease Clinics of North America|April 27, 2020
Epidermal Growth Factor Receptor Inhibitors and Other Tyrosine Kinase Inhibitors for Solid TumorsIsabel Ruiz-Camps, Juan Aguilar-Company
Enfermedades Infecciosas Y Microbiologia Clinica|June 22, 2014
[Nosocomial infection in patients receiving a solid organ transplant or haematopoietic stem cell transplant]Asunción Moreno Camacho, Isabel Ruiz Camps
Enfermedades Infecciosas Y Microbiologia Clinica|October 20, 2012
[Invasive fungal infection in haematology patients]J Carlos Vallejo Llamas, Isabel Ruiz-Camps
Enfermedades Infecciosas Y Microbiologia Clinica|July 22, 2006
[Special features of febrile neutropenia in pediatric patients]M Teresa Olivé-Oliveras, Isabel Ruiz-Camps
Medicina Clinica|November 28, 2019
Risk of infection associated with new therapies for lymphoproliferative syndromesIbai Los-Arcos, Juan Aguilar-Company, Isabel Ruiz-Camps
Revista Iberoamericana De Micologia|July 23, 2021
[Invasive fungal infection over the last 30 years]José Tiago Silva, Isabel Ruiz-Camps, José María Aguado
Frontiers in Medicine|August 1, 2022
Multidisciplinary approach to treatment with immune checkpoint inhibitors in patients with HIV, tuberculosis, or underlying autoimmune diseasesJuan Aguilar-Company, Maria A Lopez-Olivo, Isabel Ruiz-Camps
Journal of Clinical Microbiology|October 4, 2019
Molecular Diagnosis of <i>Pneumocystis jirovecii</i> Pneumonia by Use of Oral Wash Samples in Immunocompromised Patients: Usefulness and Importance of the DNA TargetLidia Goterris, Miguel Angel Mancebo Fernández, Juan Aguilar-Company, et al.
Antimicrobial Agents and Chemotherapy|December 14, 2016
Salvage Therapy with Ceftolozane-Tazobactam for Multidrug-Resistant Pseudomonas aeruginosa InfectionsJuan José Castón, Álvaro De la Torre, Isabel Ruiz-Camps, et al.
Pageof 8